| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Teleflex Incorporated (NYSE: TFX)
TFX Technical Analysis
5
| As on 16th Sep 2025 TFX STOCK Price closed @ 125.82 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 208.94 & Strong Sell for SHORT-TERM with Stoploss of 212.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TFXSTOCK Price
| Open | 126.00 | Change | Price | % |
| High | 127.42 | 1 Day | -0.07 | -0.06 |
| Low | 125.23 | 1 Week | -4.88 | -3.73 |
| Close | 125.82 | 1 Month | 9.76 | 8.41 |
| Volume | 407441 | 1 Year | -98.57 | -43.93 |
| 52 Week High 247.32 | 52 Week Low 109.79 | ||||
NYSE USA Most Active Stocks
| FSR | 0.02 | 0.00% |
| DDR | 15.44 | -4.46% |
| SNAP | 7.74 | 3.75% |
| WOLF | 2.47 | -16.55% |
| TWTR | 53.70 | 0.66% |
| NIO | 7.02 | 8.17% |
| SWN | 7.11 | -0.56% |
| BACA-U | 302.00 | 0.67% |
| ENLC | 14.12 | -0.21% |
| PFE | 23.90 | -0.29% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| TFX Daily Charts |
TFX Intraday Charts |
Whats New @ Bazaartrend |
TFX Free Analysis |
|
|
TFX Important Levels Intraday
| RESISTANCE | 130.04 |
| RESISTANCE | 128.69 |
| RESISTANCE | 127.85 |
| RESISTANCE | 127.01 |
| SUPPORT | 124.63 |
| SUPPORT | 123.79 |
| SUPPORT | 122.95 |
| SUPPORT | 121.60 |
TFX Forecast September 2025
| 4th UP Forecast | 168.75 |
| 3rd UP Forecast | 154.98 |
| 2nd UP Forecast | 146.47 |
| 1st UP Forecast | 137.96 |
| 1st DOWN Forecast | 113.68 |
| 2nd DOWN Forecast | 105.17 |
| 3rd DOWN Forecast | 96.66 |
| 4th DOWN Forecast | 82.89 |
TFX Weekly Forecast
| 4th UP Forecast | 150.99 |
| 3rd UP Forecast | 142.92 |
| 2nd UP Forecast | 137.93 |
| 1st UP Forecast | 132.94 |
| 1st DOWN Forecast | 118.70 |
| 2nd DOWN Forecast | 113.71 |
| 3rd DOWN Forecast | 108.72 |
| 4th DOWN Forecast | 100.65 |
TFX Forecast2025
| 4th UP Forecast | 397.55 |
| 3rd UP Forecast | 310.4 |
| 2nd UP Forecast | 256.54 |
| 1st UP Forecast | 202.67 |
| 1st DOWN Forecast | 48.97 |
| 2nd DOWN Forecast | -4.9 |
| 3rd DOWN Forecast | -58.76 |
| 4th DOWN Forecast | -145.91 |
Teleflex Incorporated ( NYSE USA Symbol : TFX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TFX Business Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania. Address: 550 East Swedesford Road, Wayne, PA, United States, 19087-1603
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service